InMode Appoints Michael Dennison as President of North America
Rhea-AI Summary
InMode (Nasdaq: INMD) appointed Michael Dennison as President of North America, effective Nov. 3, 2025. Dennison joins the role after nearly a decade at InMode and promotion from Vice President of Sales. The company said he progressed through roles from District Sales Manager to VP of Sales, driving national revenue growth, expanding market share, and strengthening distribution across North America.
Management said the move is part of a North American restructuring intended to advance strategic initiatives and accelerate growth. Dennison previously held multiple leadership positions at Cynosure and is described as having consistently exceeded sales targets and built high-performing teams.
Positive
- Experienced leader: nearly a decade at InMode
- Proven sales track: promoted from Vice President of Sales
- Strategic focus: role tied to North American restructuring
Negative
- Restructuring underway: North American restructuring may cause near-term operational changes
News Market Reaction
On the day this news was published, INMD declined 0.54%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market share, and strengthening the company's distribution network across
"This promotion marks an exciting new chapter for InMode, led by a visionary leader with a proven commitment to cultivating talent and driving market excellence," said Moshe Mizrahy, CEO of InMode. "Dennison's extensive industry experience and inspirational leadership will be pivotal in advancing our strategic initiatives and accelerating growth, as part of our North American restructuring."
"I am honored to continue building on InMode's strong foundation," said Dennison. "Together, we will accelerate momentum in the North American market, deliver greater value to our partners, and set new standards of excellence across the aesthetic and medical device industry."
Before joining InMode, Dennison held multiple leadership positions at Cynosure, where he consistently exceeded sales targets and built high-performing teams that drove significant revenue growth.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Photo - https://mma.prnewswire.com/media/2800683/Michael_Dennison.jpg
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-appoints-michael-dennison-as-president-of-north-america-302601451.html
SOURCE InMode Ltd.
FAQ
When did InMode appoint Michael Dennison as President of North America (INMD)?
What was Michael Dennison's role at InMode before becoming President of North America (INMD)?
How does Michael Dennison's appointment affect InMode's North American strategy (INMD)?
What experience does Michael Dennison bring from prior companies relevant to INMD?
Will Michael Dennison's promotion to President of North America change InMode's distribution approach (INMD)?
